【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Region Wise Market Calculation
1.1.1 Region Wise Market: Base Estimates
1.1.2 Global Market: CAGR Calculation
1.2 Region based segment share calculation
1.3 List of Secondary Sources
Chapter 2 Executive Summary
Chapter 3 Market Snapshot
Chapter 4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Increasing incidences of chronic diseases
4.1.1.2 Technological advancements
4.1.1.3 Growing awareness levels
4.2 Market Restraint Analysis
4.2.1.1 High cost of therapeutic mAbs
4.3 Penetration & growth prospect mapping
4.4 Monoclonal Antibodies – SWOT Analysis, By Factor (political & legal, economic and technological)
4.5 Industry Analysis – Porter’s
Chapter 5 Market Categorization 1: Source Type Estimates & Trend Analysis
5.1 Monoclonal antibodies market: Source type movement analysis
5.2 Murine
5.2.1 Murine market, 2013 – 2024 (USD Billion)
5.3 Chimeric
5.3.1 Chimeric market, 2013 – 2024 (USD Billion)
5.4 Humanized
5.4.1 Humanized market, 2013 – 2024 (USD Billion)
5.5 Human
5.5.1.1 Human market, 2013 – 2024 (USD Billion)
Chapter 6 Market Categorization 2: Production Type Estimates & Trend Analysis
6.1 Monoclonal antibodies market: Production type movement analysis
6.2 In vitro
6.2.1 In vitro market, 2013 – 2024 (USD Billion)
6.3 In vivo
6.3.1 In vivo market, 2013 – 2024 (USD Billion)
Chapter 7 Market Categorization 3: Indication Estimates & Trend Analysis
7.1 Monoclonal antibodies market: Disease movement analysis
7.2 Cancer
7.2.1 Cancer Market, 2013 – 2024 (USD Billion)
7.3 Autoimmune diseases
7.3.1 Autoimmune diseases market, 2013 – 2024 (USD Billion)
7.4 Inflammatory diseases
7.4.1 Inflammatory diseases market, 2013 – 2024 (USD Billion)
7.5 Infectious diseases
7.5.1 Infectious diseases market, 2013 – 2024 (USD Billion)
7.6 Microbial diseases
7.6.1 Microbial diseases market, 2013 – 2024 (USD Billion)
7.7 Others
7.7.1 Others diseases market, 2013 – 2024 (USD Billion)
Chapter 8 Market Categorization 4: End-Use Estimates & Trend Analysis
8.1 Monoclonal antibodies market: End-use movement analysis
8.2 Hospitals
8.2.1 Hospitals market, 2013 – 2024 (USD Billion)
8.3 Research Institutes
8.3.1 Research institutes market, 2013 – 2024 (USD Billion)
8.4 Others
8.4.1 Others market, 2013 – 2024 (USD Billion)
Chapter 9 Market Categorization 5: Regional Estimates & Trend Analysis, by Source Type, Production Type, Indication & End-Use
9.1 Monoclonal antibodies market shares by region, 2015 & 2024
9.2 North America
9.2.1 North America Monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.2 U.S.
9.2.2.1 U.S. monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.2.3 Canada
9.2.3.1 Canada monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3 Europe
9.3.1.1 Europe monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.2 Germany
9.3.2.1 Germany monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.3.3 UK
9.3.3.1 UK monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4 Asia Pacific
9.4.1.1 Asia Pacific monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.2 Japan
9.4.2.1 Japan monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.3 China
9.4.3.1 China monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.4.4 India
9.4.4.1 India monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5 Latin America
9.5.1.1 Latin America monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.2 Brazil
9.5.2.1 Brazil monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.5.3 Mexico
9.5.3.1 Mexico monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6 MEA
9.6.1.1 MEA monoclonal antibodies market estimates and forecasts, 2013 – 2024
9.6.2 South Africa
9.6.2.1 South Africa Monoclonal antibodies market estimates and forecasts, 2013 – 2024
Chapter 10 Competitive Landscape
10.1 Strategy framework
10.2 Market participation categorization
10.3 Company Profiles
10.3.1 Novartis International
10.3.1.1 Company Overview
10.3.1.2 Financial Performance
10.3.1.3 Product Benchmarking
10.3.1.4 Strategic Initiatives
10.3.2 Pfizer
10.3.2.1 Company Overview
10.3.2.2 Financial Performance
10.3.2.3 Product Benchmarking
10.3.2.4 Strategic Initiatives
10.3.3 GlaxoSmithKline Plc
10.3.3.1 Company Overview
10.3.3.2 Financial Performance
10.3.3.3 Product Benchmarking
10.3.3.4 Strategic Initiatives
10.3.4 Amgen Inc.
10.3.4.1 Company Overview
10.3.4.2 Financial Performance
10.3.4.3 Product Benchmarking
10.3.4.4 Strategic Initiatives
10.3.5 Merck & Co., Inc.
10.3.5.1 Company Overview
10.3.5.2 Financial Performance
10.3.5.3 Product Benchmarking
10.3.5.4 Strategic Initiatives
10.3.6 Daiichi Sankyo
10.3.6.1 Company Overview
10.3.6.2 Financial Performance
10.3.6.3 Product Benchmarking
10.3.6.4 Strategic Initiatives
10.3.7 Abbott Laboratories
10.3.7.1 Company Overview
10.3.7.2 Financial Performance
10.3.7.3 Product Benchmarking
10.3.7.4 Strategic Initiatives
10.3.8 AstraZeneca plc
10.3.8.1 Company Overview
10.3.8.2 Financial Performance
10.3.8.3 Product Benchmarking
10.3.8.4 Strategic Initiatives
10.3.9 Eli Lilly
10.3.9.1 Company Overview
10.3.9.2 Financial Performance
10.3.9.3 Product Benchmarking
10.3.9.4 Strategic Initiatives
10.3.10 Johnson & Johnson
10.3.10.1 Company Overview
10.3.10.2 Financial Performance
10.3.10.3 Product Benchmarking
10.3.10.4 Strategic Initiatives
10.3.11 Bayer AG
10.3.11.1 Company Overview
10.3.11.2 Financial Performance
10.3.11.3 Product Benchmarking
10.3.11.4 Strategic Initiatives
10.3.12 Bristol Myers Squibb
10.3.12.1 Company Overview
10.3.12.2 Financial Performance
10.3.12.3 Product Benchmarking
10.3.12.4 Strategic Initiatives
10.3.13 F.Hoffman-La Roche Ltd.
10.3.13.1 Company Overview
10.3.13.2 Financial Performance
10.3.13.3 Product Benchmarking
10.3.13.4 Strategic Initiatives
10.3.14 Mylan N.V.
10.3.14.1 Company Overview
10.3.14.2 Financial Performance
10.3.14.3 Product Benchmarking
10.3.14.4 Strategic Initiatives
10.3.15 Biogen Idec Inc.
10.3.15.1 Company Overview
10.3.15.2 Financial Performance
10.3.15.3 Product Benchmarking
10.3.15.4 Strategic Initiatives
10.3.16 Thermo Fisher Scientific
10.3.16.1 Company Overview
10.3.16.2 Financial Performance
10.3.16.3 Product Benchmarking
10.3.16.4 Strategic Initiatives
10.3.17 Novo Nordisk
10.3.17.1 Company Overview
10.3.17.2 Financial Performance
10.3.17.3 Product Benchmarking
10.3.17.4 Strategic Initiatives
10.3.18 Sanofi
10.3.18.1 Company Overview
10.3.18.2 Financial Performance
10.3.18.3 Product Benchmarking
10.3.18.4 Strategic Initiatives
10.3.19 Genzyme
10.3.19.1 Company Overview
10.3.19.2 Financial Performance
10.3.19.3 Product Benchmarking
10.3.19.4 Strategic Initiatives
【レポート販売概要】
■ タイトル：モノクローナル抗体（mAb）の世界市場分析：由来別（キメラ、マウス、ヒト化、ヒト）、生産タイプ別、指示別（がん、自己免疫性、炎症性、感染性、微生物性、ウイルス性疾患）、エンドユーザー別（病院、研究機関、学術機関、診療所、診断研究所）、セグメント予測、2013 – 2024■ 英文：Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use (Hospitals, Research, Academic Institutes, Clinics, Diagnostic Laboratories) And Segment Forecasts, 2013 - 2024
■ 発行日：2016年11月2日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707560
■ 調査対象地域：グローバル
- 木材敷板の世界市場2016-2020About Decking Decking is defined as a flat or profiled (anti-slip) timber surface designed as a structure to be deployed for outdoor use. Decking finds applications in the residential and non-residential sectors. Different types of woods are used for different applications. For instance, treated lumber (mainly softwood) is used for the substructure part of the deck. For the surface part of the dec …
- スマートグリッド及びスマートフォンによるエネルギー管理（Smart Grid and Smart Phones Putting Energy Management in the Hands of Consumers and Enterprise）As Smart Grid applications are deployed we will see decrease in the energy needs with 12% by 2030. However, this is not enough as there is a need for increased power supply. The primary reasons to increase worldwide energy efficiency can be grouped into four main factors: ■ Worldwide energy consumption is growing due to population growth and increased energy use per capita in both developed and de …
- 醸造用酵素の世界市場予測（～2023年）：アミラーゼ、β-グルカナーゼ、プロテアーゼ、キシラナーゼ、ALDC、ペクチナーゼThe brewing enzymes market is estimated at USD 352.1 million in 2018. It is projected to reach USD 484.7 million by 2023, at a CAGR of 6.6% from 2018, in terms of value. The use of enzymes has become increasingly important in the brewing industry, as they accelerate the chemical reaction without a change in their own structure. To enhance the brewing process, commercial exogenous enzymes are used …
- たばこ製造・販売企業分析：LorillardSynopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: Lorillard, including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand portfolio, as well as an assessment of compe …
- 世界のビジネス情報市場動向（2012-2016）TechNavio's analysts forecast the Global Business Information markets to grow at a CAGR of 4.75 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing need to develop competitive strategies. The Global Business Information markets have also been witnessing the increased penetration of smartphones and tablets. However, the increased availabili …
- 遠隔電子ユニット（REU）の世界市場予測（～2022年）：操縦面、ランディングギ、燃料システム、防氷システム“The remote electronic unit market is projected to grow at a CAGR of 12.88% from 2017 to 2022”The remote electronic unit market is projected to grow from USD 2.78 billion in 2017 to USD 5.10 billion by 2022, at a CAGR of 12.88% from 2017 to 2022. Advancements in fly-by-wire and electric actuation systems technologies, miniaturization of remote electronic units in the aerospace industry, and increa …
- ソフトウェア定義（SDx）の世界市場予測（～2024年）Increasing big data generation by enterprises and their increasing demand for virtualization and cloud in data centers to drive the market growth of SDx solutionsThe global Software-Defined Anything (SDx) market size is expected to grow from 51.7 billion in 2019 to USD 160.8 by 2024, at a Compound Annual Growth Rate (CAGR) of 25.5% during the forecast period. Organizations worldwide are increasing …
- 世界の熱可塑性ポリウレタン（TPU）市場：原料別（ポリオール、ジイソシアネート、ジオール）、種類別（ポリエステル、ポリエーテル、ポリカプロラクトン）、エンドユーズ産業別（履物、産業機械、自動車、エレクトロニクス、医療）、地域別“The TPU market is projected to register a CAGR of 7.1%, in terms of value, between 2019 and 2024.” The market size of TPU is estimated at USD 2.5 billion in 2019 and is projected to reach USD 3.5 billion by 2024, at a CAGR of 7.1%. The growth of this market is attributed to increasing consumer spending and demand for high-performance materials. There is an increased demand for TPU in automotive a …
- クリプトスポリジウム検査の世界市場2015The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- Golar LNG Limited：石油・ガスバリューチェーン分析レポート2013Golar LNG Limited Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Golar LNG Limited" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Golar LNG Limited”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the …
- 再生可能エネルギーの世界市場：インサイト、市場機会、市場シェア、市場予測The global renewable energy market grows at the CAGR of 7.50% and will contribute $1020 billion till 2022. The market is growing at a very faster pace due to rising awareness regarding renewable energy, rising substitute for petroleum products increases the biofuels demand, tax incentives by the government, investment in renewable energy by the government and so on. Decreasing cost of renewable en …
- 末梢血管装置（医療機器）のグローバル市場（2012-2018）Global Peripheral Vascular Devices sector forecasts to reach US$5 billion by 2016 at a CAGR of 10.8% during the analysis period 2012-2018. North American region accounts for highest percentage approximately 42% (2015) of global share while Europe follows next with nearly 27.7% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 12.5% driving a market value of US$1 billi …
- ヘキサメチレンジアミンの世界市場The report covers the important hexamethylenediamine global markets. It further divides the market on the basis of applications, and geography. The market data for these types is given with respect to volume (kilo tons) and value (USD Million). The market value of hexamethylenediamine was estimated at $2,904.2 million in 2014 and is projected to reach a CAGR of about 3.4% from 2014 to 2019. The da …
- 家電用ジェスチャー認識の世界市場2018-2022About gesture recognition for consumer electronic devices Gesture recognition technology analyses human motions through computer algorithms. This consists of generating gestures and capturing them using a camera. The software identifies the gesture and matches it with the database to perform the necessary action. Technavio’s analysts forecast the Global gesture recognition market for consumer elec …
- 世界の白金族元素（Platinum Group Metals）市場動向（2014～2018）TechNavio's analysts forecast the Global Platinum Group Metals market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased use of PGMs in Automotive sector. The Global PGM market has also been witnessing the increasing vehicle production worldwide. However, the supply constraints could pose a challenge to the growth …
